---
category: news
title: "Evaxionâ€™s AI technology leads to identification of new viral targets for cancer immunotherapy"
excerpt: "Evaxion Biotech A/S has developed a new proprietary artificial intelligence (AI) platform technology, Observ, to identify a new source of targets for personalized cancer therapy, potentially enabling treatment for patients with cold tumors,"
publishedDateTime: 2023-03-24T00:00:00Z
originalUrl: "https://www.bioworld.com/articles/695435-evaxions-ai-technology-leads-to-identification-of-new-viral-targets-for-cancer-immunotherapy"
webUrl: "https://www.bioworld.com/articles/695435-evaxions-ai-technology-leads-to-identification-of-new-viral-targets-for-cancer-immunotherapy"
type: article
quality: 43
heat: 43
published: false

provider:
  name: BioWorld
  domain: bioworld.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.bioworld.com/ext/resources/Stock-images/AI/AI-digital-health.png?height=635&t=1588275743&width=1200"
    width: 847
    height: 635
    isCached: true

secured: "Ec6Jhv+pzUawR/9jjCO6AI6HgOT/1a+qXeSBB2fPipF5Yx82iwfa6XWJM6kIxZfqIsPvMtbtu8wyOjXjz/awHlNwRTZnXd90upL9omp0JcBvRtoWuNam7od8qGNpOcQax+zo8sa3DYB9uf33AwWrQDwu6cuI3Mv5VKqd4NLmdzg3pHN+I6OYgdPUmeLsJmzNyfiseUEF/EpS22k7K3jxOsB0M9TEzKdUW6YXSUS+JHTggALTu8Y8zsNNv5BkamgsgfYG6e8RLLvvMH+r/e9tG3H00lsDDf3JTDNVtrG2S63PTjGyiFv7xGd8sLzUGr0t2DYePApmRnIp3ukC9iMYEHwPHEnflfXm5j511YFNyXY=;CZjOlZqdTToP1Rxz8heoPg=="
---

